Wellcome Sanger Institute Adopts Genestack’s Omics Data Manager for Human Genetic Databases

CAMBRIDGE, England – (BUSINESS SON) – Genestack Ltd. today announced that its main product catalog, healthcare and integrated search product, Omics Data Manager (ODM), has been licensed and implemented by the world’s leading center for genomics research, the Wellcome Sanger Institute.

The Wellcome Sanger Institute is a leading center for genomics research. It has been the largest contributor to the Human Genome Project and, as part of the COVID-19 Genomics UK (COG-UK) consortium, ranks the genomes of tens of thousands of positive coronavirus samples to identify super-proliferation events and new variants, and inform public health officials. Using ODM, researchers in Human Genetics at the Sanger Institute will be able to query and filter very large genetic databases using cutting-edge software technology. ODM’s capabilities also allow data scientists to produce analyzes for the researchers they support, as well as enable data managers to track and share information on multicameral samples, raw and processed data in one place, avoiding information loss or duplication, while maintaining samples. anonymity.

Dr Vivek Iyer, head of human genetics informatics at the Wellcome Sanger institute, said: “The Genestack ODM will allow bioinformatics and human genetics program scientists to comment on and share information on multicultural projects and samples, from their inception, through analysis and eventual distribution of data. Using the Genestack ODM, our research groups will be able to securely manage and easily find knowledge about our projects, their methods and analytical databases. ”

“The Sanger Institute has initiated gene sequencing and accelerated the use of extensive databases to understand human physiology and disease. We are very excited to work with such a glorious institution and help their scientists manage and collaboratively work on very large genomic data sets with powerful, yet simple, tools for interrogate and filter such data, “said Misha Kapushesky, CEO, Genestack Ltd.

The Wellcome Sanger Institute

The Wellcome Sanger Institute is a world-leading research center. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are sincere and cooperative; our data, results, tools and technologies are shared all over the world to advance science. Our ambition is vast – we are facing projects that are not possible anywhere. We use the power of genome sequencing to understand and utilize the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.


Since its founding in 2012, Genestack’s mission has been to accelerate discoveries in biopharmaceuticals, consumer goods, healthcare and agriscience, addressing the explosive growth of omics data. The company’s flagship product, Omics Data Manager, launched in 2019, helps organizations create a FAIR catalog of multi-omics data (studies, samples, associated omics data of various kinds), with tools and APIs for metadata templates, healing and powerful integrated search. across data and metadata. Genestack complements this product with a full range of professional services including technology consulting, product implementation, managed service and co-development models. For more information about Genestack and Omics Data Manager visit www.genestack.com.

Follow Genestack Limited on Linkedin, Twitter and YouTube.